Storia della carriera di Amy Edmonds
Precedenti posizioni note di Amy Edmonds
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/11/2002 | 01/10/2012 |
| BELLEROPHON THERAPEUTICS, INC. | Direttore Amministrativo | 01/09/2015 | - |
| Direttore Tecnico/Scientifico/R&S | 01/09/2015 | - | |
| Segretario Aziendale | 01/09/2015 | - |
Formazione di Amy Edmonds
| University of Richmond | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Administrative Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Amy Edmonds
- Esperienza
